-
1
المؤلفون: Nobuhiko Uoshima, Teruhito Takakuwa, Yoko Adachi, Hirokazu Tanaka, Masayuki Hino, Akifumi Takaori-Kondo, Ryosuke Yamamura, Satoru Kosugi, Hitomi Kaneko, Junya Kanda, Yuzuru Kanakura, Itaru Matsumura, Kazunori Imada, Hideo Yagi, Shin-ichi Fuchida, Junya Kuroda, Hitoji Uchiyama, Satoshi Yoshihara, Yutaka Shimazu, Chihiro Shimazaki, Mitsuhiro Matsuda, Shosaku Nomura, Hitoshi Hanamoto, Yoshiyuki Onda, Hirohiko Shibayama, Kensuke Ohta, Yuji Shimura, Aya Nakaya
المصدر: European journal of haematologyREFERENCES. 106(4)
مصطلحات موضوعية: Oncology, Boron Compounds, Male, medicine.medical_specialty, Glycine, Kaplan-Meier Estimate, Dexamethasone, Ixazomib, chemistry.chemical_compound, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Retrospective analysis, Biomarkers, Tumor, Humans, Adverse effect, Lenalidomide, Multiple myeloma, Aged, Neoplasm Staging, Retrospective Studies, Aged, 80 and over, Bortezomib, business.industry, Hematology, General Medicine, Middle Aged, medicine.disease, Prognosis, Discontinuation, Treatment Outcome, chemistry, Retreatment, Female, business, Multiple Myeloma, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::e628092ca75142bd9bc2140daa8d0281Test
https://pubmed.ncbi.nlm.nih.gov/33476404Test -
2
المؤلفون: Masayuki Kobayashi, Junya Kuroda, Toru Kida, Yuri Kamitsuji, Shin-ichi Fuchida, Takayuki Takahashi, Yoko Adachi, Hitomi Kaneko, Satoru Kosugi, Kazue Miyamoto, Tsuneyoshi Hamada, Itaru Matsumura, Hirokazu Tanaka, Chihiro Shimazaki, Akifumi Takaoari-Kondo, Hitoji Uchiyama, Hirohiko Shibayama, Kensuke Ohta, Shosaku Nomura, Hideo Yagi, Aya Nakaya, Takae Kohara, Eri Kawata, Yuji Shimura, Yuzuru Kanakura, Masayuki Hino, Fumiaki Urase, Nobuhiko Uoshima, Kansai Myeloma Forum Investigators, Maki Shindo
المصدر: Leukemia Research Reports, Vol 10, Iss, Pp 7-10 (2018)
Leukemia Research Reportsمصطلحات موضوعية: Oncology, medicine.medical_specialty, Multivariate analysis, lcsh:RC254-282, Article, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, immune system diseases, Internal medicine, hemic and lymphatic diseases, Primary plasma cell leukemia, medicine, Retrospective analysis, Significant risk, Lenalidomide, Plasma cell leukemia, Bortezomib, business.industry, Stem cell transplantation, Hematology, medicine.disease, lcsh:Neoplasms. Tumors. Oncology. Including cancer and carcinogens, surgical procedures, operative, 030220 oncology & carcinogenesis, Hypercalcemia, Novel agent, business, human activities, Median survival, 030215 immunology, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::5ba0d9bbca03060060c40221780d0d62Test
http://www.sciencedirect.com/science/article/pii/S2213048918300438Test -
3
المؤلفون: Toru Kiguchi, Junji Suzumiya, Ilsong Choi, Hiroyuki Takamatsu, Yoko Adachi, Toshiaki Yujiri, Naohito Fujishima, Toshihiro Miyamoto, Ryosuke Yamamura, Yasushi Takamatsu, Morio Matsumoto, Kazutaka Sunami, Tomonori Nakazato, Shin ichi Fuchida, Yoshiaki Kuroda, Koichi Akashi, Mine Harada, Koji Nagafuji, Eijiro Omoto, Akio Maeda
المصدر: International journal of clinical oncology. 24(8)
مصطلحات موضوعية: 0301 basic medicine, Oncology, Adult, Male, medicine.medical_specialty, Cyclophosphamide, Phases of clinical research, Transplantation, Autologous, Dexamethasone, Bortezomib, 03 medical and health sciences, 0302 clinical medicine, Autologous stem-cell transplantation, Japan, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lenalidomide, Melphalan, Multiple myeloma, Aged, business.industry, Hematology, General Medicine, Middle Aged, medicine.disease, Prognosis, Combined Modality Therapy, Neoadjuvant Therapy, Thalidomide, Transplantation, Survival Rate, 030104 developmental biology, 030220 oncology & carcinogenesis, Surgery, Female, business, Multiple Myeloma, medicine.drug, Stem Cell Transplantation
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::f03d4bdfa43fe283164dda5893f91321Test
https://pubmed.ncbi.nlm.nih.gov/30937622Test -
4
المؤلفون: Mitsuru Tsudo, Hirokazu Tanaka, Yoko Adachi, Hirohiko Shibayama, Hitomi Kaneko, Akifumi Takaori-Kondo, Kmf investigators, Kensuke Ohta, Masayuki Kobayashi, Hitoji Uchiyama, Hideo Yagi, Nobuhiko Uoshima, Junya Kuroda, Eiji Nakatani, Mitsuhiro Matsuda, Shosaku Nomura, Satoru Kosugi, Chihiro Shimazaki, Tsutomu Kobayashi, Shin-ichi Fuchida, Yuzuru Kanakura, Itaru Matsumura, Masafumi Taniwaki, Kazuyoshi Ishii
المصدر: International Journal of Hematology. 101:37-45
مصطلحات موضوعية: Adult, Male, Oncology, medicine.medical_specialty, Time Factors, Dexamethasone, Recurrence, Internal medicine, Antineoplastic Combined Chemotherapy Protocols, medicine, Humans, Lenalidomide, Survival analysis, Multiple myeloma, Aged, Neoplasm Staging, Retrospective Studies, Aged, 80 and over, Univariate analysis, business.industry, Bortezomib, Hematology, Middle Aged, Prognosis, medicine.disease, Survival Analysis, Thalidomide, Surgery, Transplantation, Treatment Outcome, Female, Multiple Myeloma, business, medicine.drug
الوصول الحر: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::6f2da39c03242694c00ce952bc2cd6f6Test
https://doi.org/10.1007/s12185-014-1696-6Test